TARIS Biomedical logo

TARIS Biomedical

A pharmaceutical company developing therapeutics for the treatment of bladder diseases

8

Funding Rounds

$113.1m

Money raised

Overview

A pharmaceutical company developing therapeutics for the treatment of bladder diseases

Funding

Funding series

Funding Series Analysis

The company TARIS Biomedical has raised a total of $46.8m in funding over 8 rounds.

Key Insights:

  • TARIS Biomedical funding round, March 2013: $13.5m
  • TARIS Biomedical Series B round: $18.3m
  • TARIS Biomedical Series A round: $15m
  • TARIS Biomedical Series B round, December 2017: $25m
  • TARIS Biomedical Venture round, October 2015: $32m
  • TARIS Biomedical Venture round, November 2012: $3.1m
  • TARIS Biomedical Venture round, July 2010: $1.2m
  • TARIS Biomedical Series A round, December 2009: $5m
TARIS Biomedical logo
TARIS Biomedical funding round, March 2013 $13.5m
TARIS Biomedical logo
TARIS Biomedical Series B round $18.3m
TARIS Biomedical logo
TARIS Biomedical Series A round $15m
TARIS Biomedical logo
TARIS Biomedical Series B round, December 2017 $25m
TARIS Biomedical logo
TARIS Biomedical Venture round, October 2015 $32m
TARIS Biomedical logo
TARIS Biomedical Venture round, November 2012 $3.1m
TARIS Biomedical logo
TARIS Biomedical Venture round, July 2010 $1.2m
TARIS Biomedical logo
TARIS Biomedical Series A round, December 2009 $5m

Industries

TARIS Biomedical is active in the following industries:
  • Biotechnology
  • Biology
  • Cancer
  • Technology
  • Healthcare
  • Pharmaceutical industry
  • Therapeutics
  • Biopharmaceutical